Health
Experimental Therapy Injected in One Eye Unexpectedly Improves Vision in The Other – ScienceAlert
In a development that could restore sight to thousands of people with an inheritable condition called Leber’s Hereditary Optic Neuropathy (LHON), scientists have…
In a development that could restore sight to thousands of people with an inheritable condition called Leber’s Hereditary Optic Neuropathy (LHON), scientists have been able to improve vision in both eyes in a majority of patients even though only one eye was actually treated.
The treatment is an experimental type of gene therapy, where tailored genetic material is injected to counteract genes that are defective or malfunctioning. With LHON, a m.11778G>A mutation in the MT-ND4 gene is the target.
…
-
Noosa News18 hours agoPill checking to resume in Queensland months after government axed funding
-
Business20 hours agoWhy Austal, Boss Energy, Harvey Norman, and NextDC shares are charging higher today
-
Business22 hours agoASX shares are expensive. Here’s why you should be buying anyway
-
Business20 hours agoBrokers name 3 ASX shares to buy today 29 August 2025